The Valeo stent: A pre-mounted, open-cell, large stent for use in small children with CHD

Frances C. Travelli, Patrick M. Sullivan, Cheryl Takao, Frank Ing

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives The aim of the present study was to determine the outcomes of using the Valeo stent (Bard Peripheral Vascular, Tempe, Arizona, United States of America) in small children with CHD. Background Stenting vascular stenoses is safe and effective in adults and older children with CHD but is limited in smaller children. The design of the Valeo stent addresses these limitations but has not been extensively described. Methods Bench testing was conducted to determine the maximum diameter of the stent, foreshortening, and side-cell diameter. A retrospective analysis of Valeo stents implanted between October, 2012 and October, 2014 was performed. Patient profile, pre-implant/post-implant catheterization data, and stent geometry were reviewed. Results Bench testing: medium and large Valeo stents can be dilated up to 13 mm and 20 mm diameters, respectively. Side-cells are dilatable up to 12 mm. Valeo stents are of low profile - delivered through 6- or 7-Fr sheaths - and show minimal foreshortening. Retrospective analysis: a total of 81 stents were implanted in 61 patients with CHD. The median weight was 15.3 kg, and the median age was 58.9 months. Stents were implanted in the pulmonary artery, systemic vein, aorta, and pulmonary vein. Overall, mean vessel diameters increased from 4.1 to 7.7 mm (121.7%). There was effective mean gradient reduction: 3.7-0.5 mmHg (63%) in the venous systems, 28.2-12.5 mmHg (63.7%) in the pulmonary arteries, and 17.4-4 mmHg (77.1%) in the aorta. The mean stent foreshortening was 2.5%, and the mean recoil was 5.9%. Side-cells that crossed other vessels were dilated in four cases, and stents were re-mounted onto different-sized balloons in seven cases. Conclusions The features of the Valeo stent, such as low profile, large maximum diameter, open-cell design, minimal foreshortening, and recoil, make it suitable for treating vascular stenoses in small children with CHD.

Original languageEnglish (US)
Pages (from-to)1187-1193
Number of pages7
JournalCardiology in the Young
Volume26
Issue number6
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Stents
Blood Vessels
Pulmonary Artery
Aorta
Pathologic Constriction
Pulmonary Veins
Catheterization
Veins
Weights and Measures

Keywords

  • intervention
  • Paediatric intravascular stenting
  • vascular stenosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

The Valeo stent : A pre-mounted, open-cell, large stent for use in small children with CHD. / Travelli, Frances C.; Sullivan, Patrick M.; Takao, Cheryl; Ing, Frank.

In: Cardiology in the Young, Vol. 26, No. 6, 01.08.2016, p. 1187-1193.

Research output: Contribution to journalArticle

Travelli, Frances C. ; Sullivan, Patrick M. ; Takao, Cheryl ; Ing, Frank. / The Valeo stent : A pre-mounted, open-cell, large stent for use in small children with CHD. In: Cardiology in the Young. 2016 ; Vol. 26, No. 6. pp. 1187-1193.
@article{3aee860e68e646768675c68b44912b2e,
title = "The Valeo stent: A pre-mounted, open-cell, large stent for use in small children with CHD",
abstract = "Objectives The aim of the present study was to determine the outcomes of using the Valeo stent (Bard Peripheral Vascular, Tempe, Arizona, United States of America) in small children with CHD. Background Stenting vascular stenoses is safe and effective in adults and older children with CHD but is limited in smaller children. The design of the Valeo stent addresses these limitations but has not been extensively described. Methods Bench testing was conducted to determine the maximum diameter of the stent, foreshortening, and side-cell diameter. A retrospective analysis of Valeo stents implanted between October, 2012 and October, 2014 was performed. Patient profile, pre-implant/post-implant catheterization data, and stent geometry were reviewed. Results Bench testing: medium and large Valeo stents can be dilated up to 13 mm and 20 mm diameters, respectively. Side-cells are dilatable up to 12 mm. Valeo stents are of low profile - delivered through 6- or 7-Fr sheaths - and show minimal foreshortening. Retrospective analysis: a total of 81 stents were implanted in 61 patients with CHD. The median weight was 15.3 kg, and the median age was 58.9 months. Stents were implanted in the pulmonary artery, systemic vein, aorta, and pulmonary vein. Overall, mean vessel diameters increased from 4.1 to 7.7 mm (121.7{\%}). There was effective mean gradient reduction: 3.7-0.5 mmHg (63{\%}) in the venous systems, 28.2-12.5 mmHg (63.7{\%}) in the pulmonary arteries, and 17.4-4 mmHg (77.1{\%}) in the aorta. The mean stent foreshortening was 2.5{\%}, and the mean recoil was 5.9{\%}. Side-cells that crossed other vessels were dilated in four cases, and stents were re-mounted onto different-sized balloons in seven cases. Conclusions The features of the Valeo stent, such as low profile, large maximum diameter, open-cell design, minimal foreshortening, and recoil, make it suitable for treating vascular stenoses in small children with CHD.",
keywords = "intervention, Paediatric intravascular stenting, vascular stenosis",
author = "Travelli, {Frances C.} and Sullivan, {Patrick M.} and Cheryl Takao and Frank Ing",
year = "2016",
month = "8",
day = "1",
doi = "10.1017/S104795111500219X",
language = "English (US)",
volume = "26",
pages = "1187--1193",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - The Valeo stent

T2 - A pre-mounted, open-cell, large stent for use in small children with CHD

AU - Travelli, Frances C.

AU - Sullivan, Patrick M.

AU - Takao, Cheryl

AU - Ing, Frank

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objectives The aim of the present study was to determine the outcomes of using the Valeo stent (Bard Peripheral Vascular, Tempe, Arizona, United States of America) in small children with CHD. Background Stenting vascular stenoses is safe and effective in adults and older children with CHD but is limited in smaller children. The design of the Valeo stent addresses these limitations but has not been extensively described. Methods Bench testing was conducted to determine the maximum diameter of the stent, foreshortening, and side-cell diameter. A retrospective analysis of Valeo stents implanted between October, 2012 and October, 2014 was performed. Patient profile, pre-implant/post-implant catheterization data, and stent geometry were reviewed. Results Bench testing: medium and large Valeo stents can be dilated up to 13 mm and 20 mm diameters, respectively. Side-cells are dilatable up to 12 mm. Valeo stents are of low profile - delivered through 6- or 7-Fr sheaths - and show minimal foreshortening. Retrospective analysis: a total of 81 stents were implanted in 61 patients with CHD. The median weight was 15.3 kg, and the median age was 58.9 months. Stents were implanted in the pulmonary artery, systemic vein, aorta, and pulmonary vein. Overall, mean vessel diameters increased from 4.1 to 7.7 mm (121.7%). There was effective mean gradient reduction: 3.7-0.5 mmHg (63%) in the venous systems, 28.2-12.5 mmHg (63.7%) in the pulmonary arteries, and 17.4-4 mmHg (77.1%) in the aorta. The mean stent foreshortening was 2.5%, and the mean recoil was 5.9%. Side-cells that crossed other vessels were dilated in four cases, and stents were re-mounted onto different-sized balloons in seven cases. Conclusions The features of the Valeo stent, such as low profile, large maximum diameter, open-cell design, minimal foreshortening, and recoil, make it suitable for treating vascular stenoses in small children with CHD.

AB - Objectives The aim of the present study was to determine the outcomes of using the Valeo stent (Bard Peripheral Vascular, Tempe, Arizona, United States of America) in small children with CHD. Background Stenting vascular stenoses is safe and effective in adults and older children with CHD but is limited in smaller children. The design of the Valeo stent addresses these limitations but has not been extensively described. Methods Bench testing was conducted to determine the maximum diameter of the stent, foreshortening, and side-cell diameter. A retrospective analysis of Valeo stents implanted between October, 2012 and October, 2014 was performed. Patient profile, pre-implant/post-implant catheterization data, and stent geometry were reviewed. Results Bench testing: medium and large Valeo stents can be dilated up to 13 mm and 20 mm diameters, respectively. Side-cells are dilatable up to 12 mm. Valeo stents are of low profile - delivered through 6- or 7-Fr sheaths - and show minimal foreshortening. Retrospective analysis: a total of 81 stents were implanted in 61 patients with CHD. The median weight was 15.3 kg, and the median age was 58.9 months. Stents were implanted in the pulmonary artery, systemic vein, aorta, and pulmonary vein. Overall, mean vessel diameters increased from 4.1 to 7.7 mm (121.7%). There was effective mean gradient reduction: 3.7-0.5 mmHg (63%) in the venous systems, 28.2-12.5 mmHg (63.7%) in the pulmonary arteries, and 17.4-4 mmHg (77.1%) in the aorta. The mean stent foreshortening was 2.5%, and the mean recoil was 5.9%. Side-cells that crossed other vessels were dilated in four cases, and stents were re-mounted onto different-sized balloons in seven cases. Conclusions The features of the Valeo stent, such as low profile, large maximum diameter, open-cell design, minimal foreshortening, and recoil, make it suitable for treating vascular stenoses in small children with CHD.

KW - intervention

KW - Paediatric intravascular stenting

KW - vascular stenosis

UR - http://www.scopus.com/inward/record.url?scp=84947911574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947911574&partnerID=8YFLogxK

U2 - 10.1017/S104795111500219X

DO - 10.1017/S104795111500219X

M3 - Article

C2 - 26593884

AN - SCOPUS:84947911574

VL - 26

SP - 1187

EP - 1193

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - 6

ER -